Â鶹Éç

Akamis Bio is an oncolytic virus drug development company whose proprietary T-SIGn virus platform enables intravenous delivery of payload carrying oncolytic viruses.

Aura Biosciences is a biopharmaceutical company aiming to transform the treatment of early-stage tumours to prevent metastasis and improve outcomes for patients with cancer.

CytoKi Pharma is a pre-clinical biotechnology company with focus on serious diseases caused by epithelial injury with a high medical need.

Dania Therapeutics is a preclinical company developing novel small molecule therapies to treat Acute myeloid leukemia (AML) and other life-threatening cancers.

Enliven Therapeutics is developing a novel, chronic, oral treatment for patients with sickle cell disease and other haemoglobinopathies.

Enterome is pioneering the development of novel microbiome based drugs to treat cancer and GI track related disorders.

The vision is to prevent death and disability for millions of people worldwide suffering from cardiovascular diseases and to reduce the burden on individuals, families, and society.

Folium Science is a company that develops feed additives using CRISPR to eliminate pathogenic bacteria in animal feed, combat food borne illness and reduce the use of antibiotics in livestock and animal agriculture

IO Biotech is a clinical stage biotech company developing disruptive immune modulating anti-cancer therapies.

Solves the toughest computational challenges by leveraging the power of quantum and high-performance computing.

Lexeo Therapautics is a gene-therapy biotechnology company developing treatments for genetically defined cardiovascular and central nervous system diseases.

NMD Pharma is a clinical stage biotech company developing treatments for neuromuscular diseases.

Notify Therapeutics is a preclinical stage company that aims to develop a first-in-class, non-hormonal treatment for infertile women who do not benefit from standard hormone therapy.

scPharmaceuticals provides subcutaneous administration of therapies that have previously been limited to intravenous, or IV, delivery reducing overall healthcare costs and advances the quality and convenience of care.

SNIPR Biome is a preclinical biotech company developing CRISPR based therapeutics with the goal of modulating the human microbiome through precision elimination of pathogenic bacteria.

Sorriso is a biopharmaceutical company advancing a pipeline of disease-modifying antibodies for the treatment of immune-mediated diseases, including Crohn’s disease and ulcerative colitis.

Spero has a pipeline of novel treatments for multi-drug resistant (MDR) bacterial infections.

Trevi Therapeutics develops Nalbuphine® ER for chronic pruritus (itch).

VarmX is a drug development company, developing drugs to restore haemostasis in case of bleeding or emergency surgery in patients taking oral factor Xa inhibitors.

Vesper Bio is a clinical stage biotech and world leader in sortilin receptor biology developing a rich pipeline of first-in-class small molecule sortilin modulators for a number of critical unmet medical needs including Frontotemporal Dementia (FTD).